Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury
[Display omitted] •Liquiritin (LIQ) dually suppresses agonist-evoked TRPV1 and TRPA1 currents.•LIQ ameliorates pathological changes in LPS-induced acute lung injury in mice.•LIQ inhibits NF-κB activation and TRPV1/A1 upregulation in lung tissues after LPS.•LIQ inhibits cytokine activation of NF-κB a...
Gespeichert in:
Veröffentlicht in: | Cell calcium (Edinburgh) 2020-06, Vol.88, p.102198-102198, Article 102198 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•Liquiritin (LIQ) dually suppresses agonist-evoked TRPV1 and TRPA1 currents.•LIQ ameliorates pathological changes in LPS-induced acute lung injury in mice.•LIQ inhibits NF-κB activation and TRPV1/A1 upregulation in lung tissues after LPS.•LIQ inhibits cytokine activation of NF-κB and TRPV1/A1 upregulation in THP-1 cells.•Positive feedback interaction of TRPV1/A1 with NF-κB signaling drives inflammation.
TRPV1 and TRPA1 are cation channels that play key roles in inflammatory signaling pathways. They are co-expressed on airway C-fibers, where they exert synergistic effects on causing inflammation and cough. Licorice, the root of Glycyrrhiza uralensis, has been widely used in China as an anti-inflammatory and anti-coughing herb. To learn if TRPV1 and TRPA1 might be key targets of the anti-inflammatory and antitussive effects of licorice, we examined liquiritin, the main flavonoid compound and active ingredient of licorice, on agonist-evoked TRPV1 and TRPA1 activation. Liquiritin inhibited capsaicin- and allyl isothiocyanate-evoked TRPV1 and TRPA1 whole-cell currents, respectively, with a similar potency and maximal inhibition. In a mouse acute lung injury (ALI) model induced by the bacterial endotoxin lipopolysaccharide, which involves both TRPV1 and TRPA1, an oral gavage of liquiritin prevented tissue damage and suppressed inflammation and the activation of NF-κB signaling pathway in the lung tissue. Liquiritin also suppressed LPS-induced increase in TRPV1 and TRPA1 protein expression in the lung tissue, as well as TRPV1 and TRPA1 mRNA levels in cells contained in mouse bronchoalveolar lavage fluid. In cultured THP-1 monocytes, liguiritin, or TRPV1 and TRPA1 antagonists capsazepine and HC030031, respectively, diminished not only cytokine-induced upregulation of NF-κB function but also TRPV1 and TRPA1 expression at both protein and mRNA levels. We conclude that the anti-inflammatory and antitussive effects of liquiritin are mediated by the dual inhibition of TRPV1 and TRPA1 channels, which are upregulated in nonneuronal cells through the NF-κB pathway during airway inflammation via a positive feedback mechanism. |
---|---|
ISSN: | 0143-4160 1532-1991 |
DOI: | 10.1016/j.ceca.2020.102198 |